These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37542773)

  • 1. Molecular and structural basis of TIGIT: Nectin-4 interaction, a recently discovered pathway crucial for cancer immunotherapy.
    Ganguli N; Kumari P; Dash S; Samanta D
    Biochem Biophys Res Commun; 2023 Oct; 677():31-37. PubMed ID: 37542773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).
    Deuss FA; Gully BS; Rossjohn J; Berry R
    J Biol Chem; 2017 Jul; 292(27):11413-11422. PubMed ID: 28515320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural, mutational and biophysical studies reveal a canonical mode of molecular recognition between immune receptor TIGIT and nectin-2.
    Samanta D; Guo H; Rubinstein R; Ramagopal UA; Almo SC
    Mol Immunol; 2017 Jan; 81():151-159. PubMed ID: 27978489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between nectin-1 and the human natural killer cell receptor CD96.
    Holmes VM; Maluquer de Motes C; Richards PT; Roldan J; Bhargava AK; Orange JS; Krummenacher C
    PLoS One; 2019; 14(2):e0212443. PubMed ID: 30759143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.
    Stanietsky N; Rovis TL; Glasner A; Seidel E; Tsukerman P; Yamin R; Enk J; Jonjic S; Mandelboim O
    Eur J Immunol; 2013 Aug; 43(8):2138-50. PubMed ID: 23677581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.
    Stanietsky N; Simic H; Arapovic J; Toporik A; Levy O; Novik A; Levine Z; Beiman M; Dassa L; Achdout H; Stern-Ginossar N; Tsukerman P; Jonjic S; Mandelboim O
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17858-63. PubMed ID: 19815499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy.
    Wu B; Zhong C; Lang Q; Liang Z; Zhang Y; Zhao X; Yu Y; Zhang H; Xu F; Tian Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):267. PubMed ID: 34433460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering.
    Stengel KF; Harden-Bowles K; Yu X; Rouge L; Yin J; Comps-Agrar L; Wiesmann C; Bazan JF; Eaton DL; Grogan JL
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5399-404. PubMed ID: 22421438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2.
    Hu S; Han P; Wang M; Cao X; Liu H; Zhang S; Zhang S; Liu J; Han Y; Xiao J; Chen Q; Miao K; Qi J; Tan S; Gao GF; Wang H
    Structure; 2024 Jul; 32(7):918-929.e4. PubMed ID: 38626767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studying TIGIT activity against tumors through the generation of knockout mice.
    Rishiq A; Bsoul R; Pick O; Mandelboim O
    Oncoimmunology; 2023; 12(1):2217735. PubMed ID: 37261087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8
    Whelan S; Ophir E; Kotturi MF; Levy O; Ganguly S; Leung L; Vaknin I; Kumar S; Dassa L; Hansen K; Bernados D; Murter B; Soni A; Taube JM; Fader AN; Wang TL; Shih IM; White M; Pardoll DM; Liang SC
    Cancer Immunol Res; 2019 Feb; 7(2):257-268. PubMed ID: 30659054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.
    de Andrade LF; Smyth MJ; Martinet L
    Immunol Cell Biol; 2014 Mar; 92(3):237-44. PubMed ID: 24343663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
    Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.
    Li M; Xia P; Du Y; Liu S; Huang G; Chen J; Zhang H; Hou N; Cheng X; Zhou L; Li P; Yang X; Fan Z
    J Biol Chem; 2014 Jun; 289(25):17647-57. PubMed ID: 24817116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma.
    Lozano E; Mena MP; Díaz T; Martin-Antonio B; León S; Rodríguez-Lobato LG; Oliver-Caldés A; Cibeira MT; Bladé J; Prat A; Rosiñol L; Fernández de Larrea C
    Clin Cancer Res; 2020 Sep; 26(17):4688-4698. PubMed ID: 32513837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracing the evolution of nectin and nectin-like cell adhesion molecules.
    Duraivelan K; Samanta D
    Sci Rep; 2020 Jun; 10(1):9434. PubMed ID: 32523039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIGIT in cancer immunotherapy.
    Chauvin JM; Zarour HM
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32900861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.
    Kaito Y; Sugimoto E; Nakamura F; Tsukune Y; Sasaki M; Yui S; Yamaguchi H; Goyama S; Nannya Y; Mitani K; Tamura H; Imai Y
    Haematologica; 2024 Apr; 109(4):1107-1120. PubMed ID: 37731380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.
    Chan CJ; Andrews DM; Smyth MJ
    Curr Opin Immunol; 2012 Apr; 24(2):246-51. PubMed ID: 22285893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1.
    Deuss FA; Watson GM; Goodall KJ; Leece I; Chatterjee S; Fu Z; Thaysen-Andersen M; Andrews DM; Rossjohn J; Berry R
    J Biol Chem; 2019 Aug; 294(33):12534-12546. PubMed ID: 31253644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.